Table 4

Characteristics of patients in moderate–severe OSA by clusters (n=1108)

VariablesCluster 1
(n=333, 30%)
Cluster 2
(n=265, 24%)
Cluster 3
(n=271, 24%)
Cluster 4
(n=239, 22%)
P for difference*
Demographics
 Male, n (%)258 (77.5%)168 (63.4%)224 (82.7%)177 (74.1%)<0.001
 Age, year49.6 (12.2)55.6 (11.5)52.5 (12.0)58.0 (11.2)<0.001
Symptom and measurements
 BMI, kg/m234.7 (5.4)25.1 (2.8)30.0 (2.3)25.5 (2.3)<0.001
 Neck circumference, cm42.8 (4.2)36.9 (2.7)40.8 (2.3)37.5 (2.3)<0.001
 Waist circumference, cm108.7 (12.0)87.4 (6.8)100.1 (5.4)88.2 (5.7)<0.001
Polysomnogram
 AHI, /hour68.2 (53.7–82.3)23.1 (18.8–28.4)35.3 (25.4–46.5)49.2 (37.8–61.0)<0.001
 TST90, min111.3 (50.3–200.6)3.8 (1.4–8.0)15.6 (6.8–27.5)40.4 (21.7–68.0)<0.001
 Mean heart rate, /min69.0 (63.1–75.0)62.5 (57.5–68.3)63.6 (57.5–70.5)64.0 (58.9–70.7)<0.001
History
 Prior hypertension, n (%)262 (78.7%)157 (59.2%)202 (74.5%)168 (70.3%)<0.001
 Prior diabetes, n (%)113 (33.9%)76 (28.7%)91 (33.6%)69 (28.9%)0.362
 Prior CVDs*, n (%)62 (18.6%)26 (9.8%)46 (17.0%)34 (14.2%)0.020
Cigarette smoking, n (%)<0.001
 No229 (73.4%)200 (74.3%)160 (74.1%)241 (59.4%)
 Former41 (13.1%)26 (9.7%)23 (10.6%)77 (19.0%)
 Current42 (17.1%)43 (14.3%)33 (17.0%)88 (18.0%)
Regular CPAP use, n (%)100 (30.0%)43 (16.2%)54 (19.9%)68 (28.5%)0.083
Incident MACEs, n (%)57 (17.1%)38 (14.3%)46 (17.0%)43 (18.0%)<0.001
Follow-up time, months93.9 (66.4–117.1)100.4 (73.3–123.4)97.7 (69.3–118.0)94.0 (67.6–119.2)0.705
  • Data are given as mean (SD), median (IQR) or n (%).

  • Characteristics among clusters were compared by analysis of variance or Kruskal-Wallis test for continuous variables and χ2 test for categorical variables.

  • *Bonferroni corrected for multiple comparisons (p ≤ (0.05/12)=p ≤ 0.004).

  • AHI, apnoea–hypopnoea index; BMI, body mass index; CPAP, continuous positive airway pressure; CVDs, cardiovascular diseases; MACEs, major adverse cardiovascular events; OSA, obstructive sleep apnoea; TST90, sleep time with oxygen saturation below 90%.